"Rote-Hand-Briefe" (equivalent to Dear Doctor Letters) and Information Letters from the year 2012
Here you will find Information Letters and so-called "Rote-Hand-Briefe" sent out by pharmaceutical companies informing healthcare experts about newly identified major drug-associated risks and measures to reduce them.
The information published here only applies to drugs which are in the BfArM's responsibility.
For "Rote-Hand-Briefe" and Information Letters published by the Paul-Ehrlich-Institute for vaccines and biomedical products please click here.
The documents listed below are available in German only.
| Title | Date | Download |
|---|---|---|
|
Information Letter on Mircera® Active substance: methoxy-polyethylenglycol-epoetin beta |
2012.02.02 |  download (file size: 886 KB) |
|
Rote-Hand-Brief on Gilenya® Active substance: fingolimod |
2012.01.26 | download (file size: 638 KB) |
|
Rote-Hand-Brief on Velcade® 1 mg, 3.5 mg, powder for solution for injection Active substance: bortezomib |
2012.01.13 | download (file size: 127 KB) |